Evidence map›Paper›PMID 41803545›Full record

ArticleAbdominal radiology (New York)2026

Development and validation of an interpretable CT-based scoring model for gastric cancer aggressiveness.

Ying-Qiao Zhang, Juan Zhang, Yu-Yao Jin, Dan Li, Wen-Juan Zhao, Peng-Yu Guo, Zhen-Nan Tian, Yang Jiang, Min Zhao, Si-Yun Liu and 9 more

Abstract readValidation StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ying-Qiao Zhang *Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Juan Zhang *Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yu-Yao JinDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Dan LiDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Wen-Juan ZhaoDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Peng-Yu GuoDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Zhen-Nan TianDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
Yang JiangDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
Min ZhaoGE HealthCare, PDx GMS Medical Affairs, Shanghai, China.
Si-Yun LiuGE HealthCare, PDx GMS Medical Affairs, Shanghai, China.
Zi-Qi WangDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Xin-Yu ZhuDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Zhen-Qi MaDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Lin SuiDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Yan-Meng LiangDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Geng HanDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China.
Zhao-Xiang YeDepartment of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Xiu-Shi ZhangDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China. xiushiz@126.com.
Yang LiuDepartment of Radiology, Harbin Medical University Cancer Hospital, Harbin, China. ly090516@126.com.

Funding

Petrel Research Program at the Harbin Medical University Cancer Hospital, China JJZD2024-14The postdoctoral scientific research developmental fund of Heilongjiang Province, China LBH-Q20144
6 · The paper itself

Abstract

objectivesAccurate prediction of adverse histopathological status (AHS) in gastric cancer (GC) is clinically crucial due to its strong association with poor prognosis. This study aims to develop and validate a CT-based machine learning model for AHS prediction, and establish an interpretable imaging score (I-score) for prognostic stratification.

methodsIn this dual-center retrospective study, 1164 GC patients undergoing radical gastrectomy between 2014 and 2023 were included. Four semantic CT features, including clinical lymph node status (cN), longest diameter (LD), tumor thickness (TT), and serosal status, were independently evaluated by radiologists. Radiomic features were extracted from arterial and portal venous phase volumes of interest. Logistic regression, support vector machine, random forest, and extreme gradient boosting (XGBoost) models were trained to predict AHS. The best-performing model was used to construct the I-score, which was validated in an independent cohort for prognostic assessment.

resultsAmong the 1164 patients (median age: 62 years old; 847 men, 317 women), data were divided into training (n = 396), test (n = 618), and validation (n = 150) cohorts. The XGBoost model using semantic features achieved the highest predictive performance (AUC: 0.803, 0.848 and 0.764, respectively). The derived I-score stratified patients into low-risk (43%) and high-risk (57%) groups, with significantly poorer 1000-day overall survival in the high-risk group (55.7% vs. 73.8%, p < 0.001). Multivariate Cox analysis confirmed the I-score as an independent prognostic factor (HR = 1.02, p = 0.004).

conclusionThe simplified CT-based machine learning model using semantic imaging features achieved high predictive performance for AHS in GC. The interpretable I-score enables effective preoperative risk stratification and individualized treatment planning.

Indexed as

Machine LearningStomach NeoplasmsTomography, X-Ray ComputedAgedFemaleGastrectomyHumansMaleMiddle AgedPrognosisRadiographic Image Interpretation, Computer-AssistedRadiomicsRetrospective StudiesAdverse histopathological statusComputed tomographyGastric cancerMachine learningRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.